A biotechnology pioneer since 1980, Amgen has reached millions of patients around the world.
"The R&D strategy is our blueprint for success in the years ahead. It describes how we plan to advance innovative therapies that patients and payers will value. It prioritizes the targets and technologies that Amgen finds most promising, and identifies ways to maximize productivity. The strategy is inspired, in part, by new and historic breakthroughs in biology. These advances are making it possible to pinpoint the molecular roots of disease, and no company is better positioned than Amgen to seize the resulting opportunities."
Executive Vice President, Research and Development
Amgen R&D strives to enhance and extend the lives of patients with serious illness. To advance this mission, we have built an organization distinguished by world-class scientists with a talent for applying novel approaches to treat disease.
In addition, we have devised an R&D strategy that aims to align and engage our talent, prioritize our investments, and seize scientific opportunities. This strategy is comprised of five major components: